StockNews.AI
MTLS
StockNews.AI
117 days

Materialise Reports First Quarter 2025 Results

1. Materialise NV reported 4.3% revenue growth, driven by 18.7% in Medical segment.

Earnings
+13.93%Current Return
VS
+2.78%S&P 500
$4.6304/24 06:35 AM EDTEvent Start
$5.27504/25 01:23 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The strong growth in the Medical segment indicates increasing demand. Historically, such growth has positively impacted stock performance.

How important is it?

Strong financial performance directly influences stock valuation and investor confidence.

Why Short Term?

Immediate investor reactions are likely based on quarterly results. Similar past earnings reports resulted in quick price upticks.

Related Companies

ADDYYBAAMZN
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2025. Highlights – First Quarter 2025 Boosted by 18.7% growth in our Materialise Medical segment, total revenue increased by 4.3% to 66,379 kEUR for the first quarter of 2025 compared to the corresponding 2024 period. Total deferred revenues from sof.

Related News